Exact Mass: 402.11841119999997
Exact Mass Matches: 402.11841119999997
Found 500 metabolites which its exact mass value is equals to given mass value 402.11841119999997,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Nobiletin
Nobiletin is a methoxyflavone that is flavone substituted by methoxy groups at positions 5, 6, 7, 8, 3 and 4 respectively. It has a role as a plant metabolite and an antineoplastic agent. It is functionally related to a flavone. Nobiletin is a natural product found in Citrus tankan, Citrus keraji, and other organisms with data available. See also: Tangerine peel (part of); Citrus aurantium fruit rind (part of). Isolated from peel of king orange (Citrus nobilis), seville orange (Citrus aurantium) and other Citrus subspecies, and the round kumquat (Fortunella japonica). Nobiletin is found in many foods, some of which are sweet bay, citrus, lemon, and grapefruit. Nobiletin is found in citrus. Nobiletin is isolated from peel of king orange (Citrus nobilis), seville orange (Citrus aurantium) and other Citrus species, and the round kumquat (Fortunella japonica A methoxyflavone that is flavone substituted by methoxy groups at positions 5, 6, 7, 8, 3 and 4 respectively. D020011 - Protective Agents > D000975 - Antioxidants Nobiletin is a poly-methoxylated flavone from the citrus peel that improves memory loss. Nobiletin is a retinoid acid receptor-related orphan receptors (RORs) agonist. Nobiletin can reduce reactive oxygen species (ROS) levels in differentiated C2C12 myotubes and has anti-inflammation and anti-cancer properties, including anti-angiogenesis, anti-proliferation, anti-metastasis and induced apoptosis[1][2][3][4]. Nobiletin is a poly-methoxylated flavone from the citrus peel that improves memory loss. Nobiletin is a retinoid acid receptor-related orphan receptors (RORs) agonist. Nobiletin can reduce reactive oxygen species (ROS) levels in differentiated C2C12 myotubes and has anti-inflammation and anti-cancer properties, including anti-angiogenesis, anti-proliferation, anti-metastasis and induced apoptosis[1][2][3][4].
1-Hydroxy-2-(beta-D-glucosyloxy)-9,10-anthraquinone
2-(2,5-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one
2-(3,5-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-chromen-4-one
Versiconol acetate
An acetate ester that is the O-acetyl derivative of versiconol. An intermediate in the biosynthesis of aflatoxin.
3-(beta-D-glucopyranosyl)-2-hydroxy-beta-oxodihydrochalcone
Hexamethylquercetagetin
3-methoxysinensetin, also known as 356734-hexamethoxyflavone, is a member of the class of compounds known as 7-o-methylated flavonoids. 7-o-methylated flavonoids are flavonoids with methoxy groups attached to the C7 atom of the flavonoid backbone. Thus, 3-methoxysinensetin is considered to be a flavonoid lipid molecule. 3-methoxysinensetin is practically insoluble (in water) and an extremely weak basic (essentially neutral) compound (based on its pKa). 3-methoxysinensetin can be found in grapefruit and sweet orange, which makes 3-methoxysinensetin a potential biomarker for the consumption of these food products. 2-(3,4-dimethoxyphenyl)-3,5,6,7-tetramethoxy-1-benzopyran-4-one is a member of flavonoids and an ether. Hexamethylquercetagetin is a natural product found in Pulicaria arabica, Chiliadenus montanus, and other organisms with data available. See also: Tangerine peel (part of); Citrus aurantium fruit rind (part of). Hexamethylquercetagetin is found in citrus. Hexamethylquercetagetin is isolated from peel of Citrus specie D004791 - Enzyme Inhibitors
3,3',4',5,7,8-Hexamethoxyflavone
3,3,4,5,7,8-Hexamethoxyflavone is an ether and a member of flavonoids. Gossypetin hexamethyl ether is a natural product found in Citrus medica, Melicope triphylla, and other organisms with data available. 3,3,4,5,7,8-Hexamethoxyflavone is found in citrus. 3,3,4,5,7,8-Hexamethoxyflavone is isolated from Valencia orange peel (Citrus sinensis) and shepherds purse (Capsella bursa-pastoris). Isolated from Valencia orange peel (Citrus sinensis) and shepherds purse (Capsella bursa-pastoris). Hexamethylgossypetin is found in sweet orange and citrus.
Sulforidazine
Sulforidazine belongs to the family of Phenothiazines. These are polycyclic aromatic compounds containing a phenothiazine moiety, which is a linear tricyclic system that consists of a two benzene rings joined by a para-thiazine ring. D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
Chrysaloin
Chrysaloin is found in herbs and spices. Chrysaloin is isolated from Rumex vesicarius (bladder dock). Isolated from Rumex vesicarius (bladder dock). Chrysaloin is found in herbs and spices.
3,3',4',5,6,8-Hexamethoxyflavone
3,3,4,5,6,8-Hexamethoxyflavone is found in citrus. 3,3,4,5,6,8-Hexamethoxyflavone is a constituent of Citrus reticulata (mandarin) Constituent of Citrus reticulata (mandarin). 3,3,4,5,6,8-Hexamethoxyflavone is found in citrus.
5-Hydroxy-3,3',7,8-tetramethoxy-4',5'-methylenedioxyflavone
5-Hydroxy-3,3,7,8-tetramethoxy-4,5-methylenedioxyflavone is found in citrus. 5-Hydroxy-3,3,7,8-tetramethoxy-4,5-methylenedioxyflavone is a constituent of the dried fruit of Citrus reticulata (mandarin). Constituent of the dried fruit of Citrus reticulata (mandarin). 5-Hydroxy-3,3,7,8-tetramethoxy-4,5-methylenedioxyflavone is found in citrus.
4-Hydroxy-5-(3',4'-dihydroxyphenyl)-valeric acid-O-glucuronide
C17H22O11 (402.11620619999997)
4-Hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid-O-glucuronide is a conjugate of 4-hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid-O-glucuronide. A glucuronide, also known as glucuronoside, is any substance produced by linking glucuronic acid to another substance via a glycosidic bond. The glucuronides belong to the glycosides. (Wikipedia)
4-Hydroxy-5-(3',5'-dihydroxyphenyl)-valeric acid-O-glucuronide
C17H22O11 (402.11620619999997)
4-Hydroxy-5-(3,5-dihydroxyphenyl)-valeric acid-O-glucuronide is a conjugate of 4-hydroxy-5-(3,5-dihydroxyphenyl)-valeric acid and glucuronide. A glucuronide, also known as glucuronoside, is any substance produced by linking glucuronic acid to another substance via a glycosidic bond. The glucuronides belong to the glycosides. (Wikipedia)
6-[4-(4-carboxy-2-hydroxybutyl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
C17H22O11 (402.11620619999997)
6-[4-(4-carboxy-2-hydroxybutyl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 5-(3,4-dihydroxyphenyl)-4-hydroxypentanoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.
6-[5-(4-carboxy-2-hydroxybutyl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
C17H22O11 (402.11620619999997)
6-[5-(4-carboxy-2-hydroxybutyl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 5-(3,4-dihydroxyphenyl)-4-hydroxypentanoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.
4-Hydroxy-5-(3',5'-dihydroxyphenyl)-valeric acid glucuronide
C17H22O11 (402.11620619999997)
(Z)-6-[(2S,4S,5R)-2-(2-Chlorophenyl)-4-(2-hydroxyphenyl)-1,3-dioxan-5-yl]hex-4-enoic acid
C22H23ClO5 (402.12339380000003)
Rafabegron
C21H23ClN2O4 (402.13462680000004)
Setipiprant
C24H19FN2O3 (402.13796360000003)
C308 - Immunotherapeutic Agent > C574 - Immunosuppressant C177182 - Prostaglandin Receptor Antagonist
Apigenin 7-arabinoside
Apigenin 7-arabinoside is a member of the class of compounds known as flavonoid-7-o-glycosides. Flavonoid-7-o-glycosides are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to carbohydrate moiety at the C7-position. Apigenin 7-arabinoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Apigenin 7-arabinoside can be found in chicory, which makes apigenin 7-arabinoside a potential biomarker for the consumption of this food product.
8-p-Coumaroyl-3,4-dihydro-5,7-dihydroxy-4-phenylcoumarin
Calomelanol I
Calomelanol H
Inophyllum E
Austradiol diacetate
beta-isorhodomycinone
5,2,5-Trihydroxy-3,7,8-trimethoxyflavone 2-acetate
5-Demethylmelibentin
2-(1,3-Benzodioxol-5-yl)-7-hydroxy-3,5,6,8-tetramethoxy-4H-1-benzopyran-4-one
7-Hydroxy-5,6,8,3-tetramethoxy-4,5-methylenedioxyflavone
Bannamurpanisin
Bannamurpanisin is a natural product found in Neoraputia alba and Murraya paniculata with data available.
Tomentolide A
Ulexone B
Nobiletin
D020011 - Protective Agents > D000975 - Antioxidants Nobiletin is a poly-methoxylated flavone from the citrus peel that improves memory loss. Nobiletin is a retinoid acid receptor-related orphan receptors (RORs) agonist. Nobiletin can reduce reactive oxygen species (ROS) levels in differentiated C2C12 myotubes and has anti-inflammation and anti-cancer properties, including anti-angiogenesis, anti-proliferation, anti-metastasis and induced apoptosis[1][2][3][4]. Nobiletin is a poly-methoxylated flavone from the citrus peel that improves memory loss. Nobiletin is a retinoid acid receptor-related orphan receptors (RORs) agonist. Nobiletin can reduce reactive oxygen species (ROS) levels in differentiated C2C12 myotubes and has anti-inflammation and anti-cancer properties, including anti-angiogenesis, anti-proliferation, anti-metastasis and induced apoptosis[1][2][3][4].
Besonprodil
C21H23FN2O3S (402.14133400000003)
CONFIDENCE standard compound; INTERNAL_ID 264; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3293; ORIGINAL_PRECURSOR_SCAN_NO 3290 C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent CONFIDENCE standard compound; INTERNAL_ID 264; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3290; ORIGINAL_PRECURSOR_SCAN_NO 3287 CONFIDENCE standard compound; INTERNAL_ID 264; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3297; ORIGINAL_PRECURSOR_SCAN_NO 3295 CONFIDENCE standard compound; INTERNAL_ID 264; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3287; ORIGINAL_PRECURSOR_SCAN_NO 3286 CONFIDENCE standard compound; INTERNAL_ID 264; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3363; ORIGINAL_PRECURSOR_SCAN_NO 3361 CONFIDENCE standard compound; INTERNAL_ID 264; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3296; ORIGINAL_PRECURSOR_SCAN_NO 3294 CONFIDENCE standard compound; INTERNAL_ID 264; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6916; ORIGINAL_PRECURSOR_SCAN_NO 6915 CONFIDENCE standard compound; INTERNAL_ID 264; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6924; ORIGINAL_PRECURSOR_SCAN_NO 6919 ORIGINAL_ACQUISITION_NO 6950; CONFIDENCE standard compound; INTERNAL_ID 264; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_PRECURSOR_SCAN_NO 6945 CONFIDENCE standard compound; INTERNAL_ID 264; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6950; ORIGINAL_PRECURSOR_SCAN_NO 6945 CONFIDENCE standard compound; INTERNAL_ID 264; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6975; ORIGINAL_PRECURSOR_SCAN_NO 6972 CONFIDENCE standard compound; INTERNAL_ID 264; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6952; ORIGINAL_PRECURSOR_SCAN_NO 6949 CONFIDENCE standard compound; INTERNAL_ID 264; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6971; ORIGINAL_PRECURSOR_SCAN_NO 6968
Apodanthoside (Not validated)
C17H22O11 (402.11620619999997)
Annotation level-3
rel-(2E)-3-[(2R,3S)-2,3-dihydro-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-7-methoxybenzofuran-5-yl]prop-2-enoic acid|rel-(7R,7E,8S)-4,9-dihydroxy-3,3,5-trimethoxy-4,7-epoxy-8,5-neolign-7-en-9-oic acid
bilagrewin|rel-3-[3S-(4-hydroxy-3,5-dimethoxyphenyl)-2R-hydroxymethyl-8-methoxy-2,3-dihydrobenzo[1,4]dioxin-6-yl]propenal
3,4,9,10-Tetra-Me ether,Ac-3,4,8,9,10-Pentahydroxypterocarpan
3,7,8-Tri-Me ether,2-Ac-2,3,5,5,7,8-Hexahydroxyflavone|5,5-dihydroxy-3,7,8-trimethoxy-2-acetoxyflavone
9-(acetyloxy)-8,8-dimethyl-2-oxo-9,10-dihydro-2H,8H-pyrano[2,3-f]chromen-10-yl 2,3-dimethyloxirane-2-carboxylate
(3aS,4S,8bS,E)-8,8-dimethyl-3-(((R)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-2,7-dioxo-3,3a,4,5,6,7,8,8b-octahydro-2H-indeno[1,2-b]furan-4-yl acetate|7-oxoorobanchyl acetate
3,3-Ethylidenebis(2-methyl-5-hydroxy-1,4-naphthoquinone)
Hexa-Me ether-1,2,4,5,6,7-Hexahydroxy-3-methylanthraquinone
3,4,5,5,7-pentahydroxy-3-methoxy-6-(3-methyl-2-butenyl) flavanone
3,6-Ethylidenebis(2-methyl-5-hydroxy-1,4-naphthoquinone)
2beta-syringyl-4-oxo-6beta-guaiacyl-3,7-dioxabicyclo[3.3.0]octane|mayuenolide
3,4-demethylenepodophyllotoxin|6,7-O,O-demethylenepodophyllotoxin|6,7-O-Demethylen-podophyllotoxin
7,8-dihydro-7-(3-methoxy-4,5-dihydroxyphenyl)-8-(hydroxymethyl)-6-methoxy-2H-pyrano[2,3-f]-7,8-benzodioxin-2-one|malloapelin C
1-O,2-O-[(1S,2S)-1-(3-acetyl-2,4,6-trihydroxyphenyl)-3-hydroxypropane-1,2-diyl]-beta-D-glucopyranose|1-O,2-O-[(1S,2S)-1-(3-acetyl-2,4,6-trihydroxyphenyl)-3-hydroxypropane-1,3-diyl]-beta-D-glucopyranose|tomentoside II
C17H22O11 (402.11620619999997)
(-)-rel-(1R,2S)-1-(3-hydroxy-4,5-dimethoxyphenyl)-2-methyl-3-oxobutyl 1,3-benzodioxole-5-carboxylate|(-)-rel-(7R,8S)-5-hydroxy-3,4-dimethoxy-3,4-(methylenedioxy)-7,7-epoxy-7,8-secolignan-7,8-dione|marlignan B|marphenol B
4-Methoxy-6-(3-methyl-2,3-diacetoxybutyl)-7H-furo[3,2-g][1]benzopyran-7-one
6-C-alpha-arabinofuranosylapigenin|apigenin 6-C-alpha-arabinofuranoside
1-hydroxy-2-(3,4-methylenedioxy)phenoxy-6-(2-hydroxy-3,4-methylenedioxy)phenyl-3,7-dioxabicyclo[3.3.0]octane|phrymarolin B|phrymarolin III|rel-(1R,3aR,4S,6aS)-4-(1,3-benzodioxol-5-yloxy)dihydro-1-(4-hydroxy-1,3-benzodioxol-5-yl)-1H,3H-furo[3,4-c]furan-3a(4H)-ol
2-(2,5-Dimethoxyphenyl)-3,6,7,8-tetramethoxy-4H-1-benzopyran-4-one
(7S,8S,8aS)-7-hydroxy-3-[(1E)-3-hydroxyprop-1-en-1-yl]-7-methyl-6-oxo-6,7,8,8a-tetrahydro-1H-isochromen-8-yl 2,4-dihydroxy-6-methylbenzoate|pinophilin B
2-(2,5-dimethoxyphenyl)-3,5,7,8-tetramethoxy-4H-1-benzopyran-4-one|3,5,7,8,2,5-hexamethoxyflavone
2,5-dihydroxy-4-methoxyphenanthrene 2-O-beta-D-glucopyranoside|denneanoside A
graminone B
A lignan that is tetrahydro-1H,3H-furo[3,4-c]furan-1-one substituted by a 3-hydroxy-4,5-dimethoxyphenyl at position 3 and a 3-hydroxy-4,5-dimethoxyphenyl group at position 5. Isolated from the rhizomes of Imperata cylindrica, it exhibits vasodilative activity.
(2S)-8-C-beta-glucopyranosyl-7-hydroxyflavanone|schoepfiajasmin E
(R)-3-(3,4-dihydroxy-phenyl)-acrylic acid 2-(3,4-dihydroxy-phenyl)-1-propoxycarbonyl ethyl ester|n-propyl rosmarinate
2,6-dihydroxyanthraquinone 2-beta-D-glucopyranoside
8alpha-(2-methylacryloyloxy)-3-oxo-1-desoxy-1,2-dehydrohirsutinolide-13-O-acetate
(E)-resveratrol 3-(4-acetyl)-O-beta-D-xylopyranoside
Integrastatin B
An organic heterotetracyclic compound that is 11,12-dihydro-6H-6,12-epoxydibenzo[b,f]oxocine substituted by hydroxy groups at positions 4, 7 and 8, methoxy groups at positions 3 and 9, methyl groups at positions 6 and 12, an oxo group at position 11 and a formyl group at position 1. It is isolated as a racemate from Ascochyta and exhibits inhibitory activity against HIV-1 integrase.
5-Hydroxy-2,2-dimethyl-6-<(E)-2-methylbut-2-enoyl>-10-phenyl-2H,8H-benzo<1,2-b:3,4-b>dipyran-8-one|calophyllolide
6-hydroxy-2-(4-hydroxybenzyl)benzofuran-7-C-beta-D-glucopyranoside|6-hydroxy-2-p-hydroxybenzylbenzofuran-7-C-beta-D-glucopyranoside|pteroside
3,4,5,5,6,7-HEXAMETHOXYFLAVONE
5,6,7,3,4,5-Hexamethoxyflavone is a natural product found in Ficus maxima, Murraya paniculata, and other organisms with data available.
4-Methoxy-benzoic acid 4-(4-methoxy-phenyl)-2-oxo-2H-chromen-7-yl ester
(2S)-2-phenyl-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3-dihydrochromen-4-one
(5-benzoyloxy-3-chloro-4,6-dihydroxycyclohexen-1-yl)methyl benzoate
C21H19ClO6 (402.08701040000005)
(2S)-2-phenyl-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3-dihydrochromen-4-one
(5-benzoyloxy-2-chloro-1,6-dihydroxycyclohex-3-en-1-yl)methyl benzoate
C21H19ClO6 (402.08701040000005)
Cys Gly His Ser
Cys Gly Ser His
Cys His Gly Ser
Cys His Ser Gly
Cys Ser Gly His
Cys Ser His Gly
Asp Asp Gly Pro
Asp Asp Pro Gly
Asp Gly Asp Pro
Asp Gly Pro Asp
Asp Pro Asp Gly
Asp Pro Gly Asp
Gly Cys His Ser
Gly Cys Ser His
Gly Asp Asp Pro
Gly Asp Pro Asp
Gly His Cys Ser
Gly His Ser Cys
Gly Pro Asp Asp
Gly Ser Cys His
Gly Ser His Cys
His Cys Gly Ser
His Cys Ser Gly
His Gly Cys Ser
His Gly Ser Cys
His Ser Cys Gly
His Ser Gly Cys
Pro Asp Asp Gly
Pro Asp Gly Asp
Pro Gly Asp Asp
Ser Cys Gly His
Ser Cys His Gly
Ser Gly Cys His
Ser Gly His Cys
Ser His Cys Gly
Ser His Gly Cys
Chrysaloin
5-Hydroxy-3,3',7,8-tetramethoxy-4',5'-methylenedioxyflavone
(2S,4S)-METHYL 4-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)PYRROLIDINE-2-CARBOXYLATE HYDROCHLORIDE
C21H23ClN2O4 (402.13462680000004)
(2,2-DIMETHOXY-[1,1-BINAPHTHALENE]-3,3-DIYL)DIBORONIC ACID
C22H20B2O6 (402.14459200000005)
2-Biphenylyl diphenyl phosphate suppliers in China
C24H19O4P (402.10209040000007)
5-O-CARBOMETHOXY-1,2-O-ISO-PROPYLIDENE-3-O-(P-TOLYL-SULFONYL)-ALPHA-D-XYLOFURANOSE
(1R,2S)-1-Amino-N-(cyclopropylsulfonyl)-2-ethenylcyclopropanecarboxamide 4-methylbenzenesulfonate
4-[(4-Chlorophenyl) phenylmethyl]-piperidine dihydrochloride
5-(2-BENZOTHIAZOLYL)-1-(4-NITROPHENYL)-3-PHENYLFORMAZAN
2-Bromo-5-dodecyl-2,5-cyclohexadiene-1,4-diylidenebiscyanamide
2,5-diethoxy-4-(p-tolylthio)benzenediazonium tetrafluoroborate
Methyl (2S,4S)-1-Fmoc-4-aminopyrrolidine-2-carboxylate hydrochloride
C21H23ClN2O4 (402.13462680000004)
4-(FMOC-AMINO)-4-PIPERIDINECARBOXYLIC ACID HYDROCHLORIDE
C21H23ClN2O4 (402.13462680000004)
4-[2-(3,4-Dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1H)-isoquinolinyl)ethyl]benzenesulfonamide
C20H22N2O5S (402.12493620000004)
Chaetominine
An organic heterotetracyclic compound that consists of 4,5,5a,9c-tetrahydro-3H-2a,9b-diazacyclopenta[jk]fluorene-1,3(2H)-dione substituted by a hydroxy group at position 5, a methyl group at position 2 and a 4-oxoquinazolin-3(4H)-yl group at position 4 (the 2S,4R,5aS,9cS stereoisomer). It is a cytotoxic alkaloid isolated from the endophytic fungus Chaetomium.
3H-Thieno[2,3-d]imidazole-5-carboxylic acid,3-cyclohexyl-2,6-diphenyl-
2-ACETAMIDO-2-DEOXY-D-GLUCONHYDROXIMO-1,5-LACTONE 1-N,3,4,6-TETRAACETATE
(Z)-3-((2-(N-hydroxycarbaMiMidoyl)biphenyl-4-yl)Methyl)-2-oxo-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylic acid
3-Deoxy-3-fluoro-beta-D-ribofuranose 1-acetate 2,5-dibenzoate
(R)-4-(anthracen-9-yl)-3-(tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole
O6-Cyclohexylmethoxy-2-(4-sulphamoylanilino) purine
Rilpivirine hydrochloride
C22H19ClN6 (402.13596440000003)
C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent
VARESPLADIB sodium
C21H19N2NaO5 (402.11916040000006)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic Varespladib sodium (LY315920 sodium) is a potent and selective group IIA, secretory phospholipase A2 (sPLA2) inhibitor with an IC50 of 9 nM. Varespladib sodium exhibits the significant inhibitory effect on sPLA2 activity in serum from various species including rat, rabbit, guinea pig and human with IC50s of 8.1 nM, 5.0 nM, 3.2 nM and 6.2 nM, respectively[1].
5-amino-N-tert-butyl-4-(3-methoxyphenyl)-2-(methylthio)-6-thieno[2,3-d]pyrimidinecarboxamide
C19H22N4O2S2 (402.11841119999997)
4-(6-Amino-5-cyano-3-methyl-1,4-dihydropyrano[2,3-c]pyrazol-4-yl)-2-methoxyphenyl benzoate
2-Methoxyethyl 5-{[5-(methoxycarbonyl)-2-methylfuran-3-yl]methoxy}-2-methyl-1-benzofuran-3-carboxylate
4-[[[2-(4-Methoxyphenyl)-3-thiazolidinyl]-sulfanylidenemethyl]amino]benzoic acid ethyl ester
C20H22N2O3S2 (402.10717819999996)
4-(4-methoxyphenyl)-2-oxo-2H-chromen-7-yl 4-methoxybenzoate
(1S,6alpha)-1-(Benzoyloxy)methyl-6-chloro-4-cyclohexene-1beta,2beta,3alpha-triol 3-benzoate
C21H19ClO6 (402.08701040000005)
5-(2-Ethoxyethyl)-5-[4-(4-fluorophenoxy)phenoxy]pyrimidine-2,4,6(1H,3H,5H)-trione
6-{4-[Hydroxy-(4-nitro-phenoxy)-phosphoryl]-butyrylamino}-hexanoic acid
3-(6-Cyclohexylmethoxy-9H-purin-2-ylamino)-benzenesulfonamide
4-{[5-(Cyclohexylmethoxy)[1,2,4]triazolo[1,5-A]pyrimidin-7-YL]amino}benzenesulfonamide
Setipiprant
C24H19FN2O3 (402.13796360000003)
C308 - Immunotherapeutic Agent > C574 - Immunosuppressant C177182 - Prostaglandin Receptor Antagonist
5-chloro-6-methyl-N-[2-(4-methylsulfonylphenyl)ethyl]-2-pyridin-2-ylpyrimidin-4-amine
5,7-Dihydroxy-2-(4-hydroxyphenyl)-8-(3,4,5-trihydroxyoxan-2-yl)chromen-4-one
1-hydroxy-2-[(2R,3R,4S,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyanthracene-9,10-dione
(E)-6-[2-(2-chlorophenyl)-4-(2-hydroxyphenyl)-1,3-dioxan-5-yl]hex-4-enoic acid
C22H23ClO5 (402.12339380000003)
4-Hydroxy-5-(3,5-dihydroxyphenyl)-valeric acid glucuronide
C17H22O11 (402.11620619999997)
variecolorquinone A
An dihydroxyanthraquinone that is 1,6-dihydroxy-9,10-anthraquinone which is substituted by a methoxy group at position 8, a methyl group at position 3 and a [(2S)-2,3-dihydroxypropoxy]carbonyl group at position 2. Isolated from the fungus Aspergillus variecolor, it exhibits cytotoxic activity.
N-[4-(1H-benzimidazol-2-yl)phenyl]-4-ethoxy-3-nitrobenzamide
4-Chloro-3-(1-pyrrolidinylsulfonyl)benzoic acid [2-(butylamino)-2-oxoethyl] ester
C17H23ClN2O5S (402.10161380000005)
3-(4-chlorophenyl)-1-methyl-N-[3-(1-pyrrolidinyl)propyl]-5-thieno[2,3-c]pyrazolecarboxamide
N-[4-[5-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-4-pyridinecarboxamide
3-[[[2-(3-Methylphenyl)-4-quinolinyl]-oxomethyl]amino]-2-thiophenecarboxylic acid methyl ester
N-[5-(1H-benzimidazol-2-yl)-2-methylphenyl]-2-(2-nitrophenoxy)acetamide
2-[[Cyclohexyl(oxo)methyl]amino]-4-(3-nitrophenyl)-3-thiophenecarboxylic acid ethyl ester
C20H22N2O5S (402.12493620000004)
2-[[5-[(2-Chloroanilino)methyl]-4-phenyl-1,2,4-triazol-3-yl]thio]acetic acid ethyl ester
(1R,9aR)-octahydro-2H-quinolizin-1-ylmethyl (4-chlorophenoxy)sulfonylcarbamate
C17H23ClN2O5S (402.10161380000005)
4-[[[4-(2-Furanylmethyl)-5-(3-methoxyphenyl)-1,2,4-triazol-3-yl]thio]methyl]benzonitrile
2-(butylamino)-3-(3-chlorophenyl)-7-methyl-6,8-dihydro-5H-pyrido[2,3]thieno[2,4-b]pyrimidin-4-one
N-[5-[2-(2-methoxyanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]pentanamide
C19H22N4O2S2 (402.11841119999997)
N-[5-[2-(3-methoxyanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]-3-methylbutanamide
C19H22N4O2S2 (402.11841119999997)
6-[5-Chloro-3-methyl-1-(4-methylphenyl)-4-pyrazolyl]-3,4-dimethyl-2-oxo-1,6-dihydropyrimidine-5-carboxylic acid ethyl ester
C20H23ClN4O3 (402.14585980000004)
(2R,3R,4S)-2-cyano-N-(4-fluorophenyl)-4-(hydroxymethyl)-3-[4-(3-pyridinyl)phenyl]-1-azetidinecarboxamide
(2S,3S,4R)-2-cyano-N-(4-fluorophenyl)-4-(hydroxymethyl)-3-(4-pyridin-3-ylphenyl)azetidine-1-carboxamide
(2S,3R,4R)-2-cyano-N-(4-fluorophenyl)-4-(hydroxymethyl)-3-[4-(3-pyridinyl)phenyl]-1-azetidinecarboxamide
(2R,3S,4R)-2-cyano-N-(4-fluorophenyl)-4-(hydroxymethyl)-3-(4-pyridin-3-ylphenyl)azetidine-1-carboxamide
6-[5-(3,4-Dihydroxyphenyl)-4-hydroxypentanoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
C17H22O11 (402.11620619999997)
4,5-Dioxo-2-phenyl-1-(4-sulfamoylphenyl)-3-pyrrolidinecarboxylic acid ethyl ester
C19H18N2O6S (402.08855280000006)
(1S,5R)-8-methyl-3-[(4-nitrophenoxy)-phenylphosphoryl]oxy-8-azabicyclo[3.2.1]octane
(1S,9S)-6,11,12-Trihydroxy-5,13-dimethoxy-1,9-dimethyl-16-oxo-8,17-dioxatetracyclo[7.7.1.02,7.010,15]heptadeca-2(7),3,5,10,12,14-hexaene-3-carbaldehyde
(3R,4R)-3-Epoxyangeloyloxy-4-acetoxy-3,4-dihydroseselin
(3S)-versiconol acetate
An optically active form of versiconol acetate having 3S-configuration.
2,5-diiminio-3,4-bis(indol-3-yl)hexanedioate
A zwitterion that is derived from 2,5-diimino-3,4-bis(indol-3-yl)hexanedioic acid by deprotonation of both carboxylic acid groups and protonation of both amino groups; major species at pH 7.3.
2,5-diimino-3,4-bis(indol-3-yl)hexanedioic acid
A member of the class of indoles obtained by dimerisation of 2-imino-3-(indol-3-yl)propanoic acid. An intermediate in the biosynthesis of violacein.
Sulforidazine
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
4-Hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid-O-glucuronide
C17H22O11 (402.11620619999997)
4-Hydroxy-5-(3,5-dihydroxyphenyl)-valeric acid-O-glucuronide
C17H22O11 (402.11620619999997)
6-[2-(2-chlorophenyl)-4-(2-hydroxyphenyl)-1,3-dioxan-5-yl]-4-hexenoic acid
C22H23ClO5 (402.12339380000003)
5-Hydroxy-3,3,7,8-tetramethoxy-4,5-methylenedioxyflavone
6-[4-(4-carboxy-2-hydroxybutyl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
C17H22O11 (402.11620619999997)
6-[5-(4-carboxy-2-hydroxybutyl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
C17H22O11 (402.11620619999997)
Mollicellin J
C21H19ClO6 (402.08701040000005)
A member of the class of depsidones that is 11H-dibenzo[b,e][1,4]dioxepine substituted by a chloro group at position 2, hydroxy groups at position 3 and 7, methyl group at positions 1 and 9, a prenyl group at position 8, an oxo group at position 11 and a formyl group at position 4. Isolated from Chaetomium brasiliense it exhibits cytotoxic activity.
N-(4-chlorophenoxy)sulfonylcarbamic acid [(1R,9aR)-2,3,4,6,7,8,9,9a-octahydro-1H-quinolizin-1-yl]methyl ester
C17H23ClN2O5S (402.10161380000005)
7-hydroxyflavanone 7-O-beta-D-glucoside
A flavanone 7-O-beta-D-glucoside that consists of 7-hydroxyflavanone attached to a beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage.
Fuzapladib (sodium)
C15H20F3N3NaO3S (402.10751060000007)
Fuzapladib (IS-741) sodium, an orally active leukocyte-function-associated antigen type 1 (LFA-1) activation inhibitor, is a leukocyte adhesion molecule. Fuzapladib sodium is also a phospholipase A2 (PLA2) inhibitor. Fuzapladib sodium exerts anti-inflammatory effects by inhibiting leukocyte migration into the inflammatory site[1][2].
PNU-177864
PNU-177864 is a potent, selective and orally active dopamine D3 receptor antagonist. PNU-177864 is structurally consistent with a cationic amphiphilic agent (CAD) and induces phospholipidosis in vivo. PNU-177864 antischizophrenic activity[1][2].
VU-1545
VU-1545 is a metabotropic glutamate receptor 5 positive allosteric modulator (mGluR5 PAM) with a Ki of 156 nM and an EC50 of 9.6 nM[1].
1-(2-hydroxyphenyl)-3-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-en-1-one
(9s,10s)-9-(acetyloxy)-8,8-dimethyl-2-oxo-9h,10h-pyrano[2,3-h]chromen-10-yl (2r,3r)-2,3-dimethyloxirane-2-carboxylate
3-{[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-1,8-dihydroxy-6-methylanthracene-9,10-dione
5,6-dimethoxy-2-(2,3,4,6-tetramethoxyphenyl)chromen-4-one
(6r,7r)-6,7,10,10-tetramethyl-4-phenyl-6,7-dihydro-1,5,9-trioxatriphenylene-2,8-dione
2-benzyl-3-{[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-2-hydroxybutanedioic acid
(2s,3s)-3-(3,4-dihydroxy-5-methoxyphenyl)-2-(hydroxymethyl)-5-methoxy-2h,3h-[1,4]dioxino[2,3-h]chromen-9-one
13-hydroxy-4-(hydroxymethyl)-5,17-dimethoxy-7,12-dimethyl-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(11),3,5,7,12,14(18)-hexaene-9,15-dione
11-hydroxy-5-methyl-2-[(2r,3s)-2-methyl-3-[(1e)-prop-1-en-1-yl]oxiran-2-yl]-1-oxatetraphene-4,7,12-trione
(3s,4s)-3-[(3,4-dihydroxy-5-methoxyphenyl)methyl]-4-[(7-methoxy-2h-1,3-benzodioxol-5-yl)methyl]oxolan-2-one
(2r)-1-[(1s,2s)-2-[(s)-hydroxy[(2r)-6-oxo-2,3-dihydropyran-2-yl]methyl]cyclopropyl]-1-oxopropan-2-yl (2z)-3-(3,4-dihydroxyphenyl)prop-2-enoate
5,6,8-trimethoxy-2-(3,4,5-trimethoxyphenyl)chromen-4-one
methyl 15,17-dihydroxy-7-methoxy-5,16-dimethyl-13-oxo-2,10,12-trioxatetracyclo[9.6.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3(8),4,6,14(18),15-hexaene-4-carboxylate
methyl 4-(3-formyl-2,4-dihydroxy-5,6-dimethylbenzoyloxy)-2-hydroxy-3,5,6-trimethylbenzoate
5-hydroxy-6-[1-(8-hydroxy-3-methyl-1,4-dioxonaphthalen-2-yl)ethyl]-2-methylnaphthalene-1,4-dione
5-hydroxy-9-(4-hydroxyphenyl)-2,2-dimethyl-6-[(1e)-3-methylbuta-1,3-dien-1-yl]pyrano[2,3-h]chromen-10-one
2-{[2-({2-amino-1-hydroxy-4-[methyl(oxo)(phosphonoimino)-λ⁶-sulfanyl]butylidene}amino)-1-hydroxypropylidene]amino}propanoic acid
3,5,7-trimethoxy-2-(2,4,5-trimethoxyphenyl)chromen-4-one
(2s,3r,4r,5s,6r)-2-{6-hydroxy-2-[(4-hydroxyphenyl)methyl]-1-benzofuran-7-yl}-6-(hydroxymethyl)oxane-3,4,5-triol
1-hydroxy-10-methyl-13-(4-oxoquinazolin-3-yl)-8,11-diazatetracyclo[6.6.1.0²,⁷.0¹¹,¹⁵]pentadeca-2,4,6-triene-9,12-dione
10-chloro-2,11-dihydroxy-2,6,11-trimethyl-7-oxo-8,14-dioxatetracyclo[8.4.0.0¹,¹³.0⁵,⁹]tetradecan-4-yl 2-methylpropanoate
(1s,10s,13s,15s)-1-hydroxy-10-methyl-13-(4-oxoquinazolin-3-yl)-8,11-diazatetracyclo[6.6.1.0²,⁷.0¹¹,¹⁵]pentadeca-2,4,6-triene-9,12-dione
(2e)-6-[(acetyloxy)methyl]-1,10-dimethyl-5,13-dioxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6,11-trien-8-yl 2-methylprop-2-enoate
(10'r,12'r,15'r)-1',6',9',10'-tetrahydroxy-12'-methyl-3h-13'-oxaspiro[pyran-2,16'-tetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁵]hexadecane]-2',4',6'-triene-6,8',14'-trione
1-[(1s,2s)-2-[(s)-hydroxy[(2r)-6-oxo-2,3-dihydropyran-2-yl]methyl]cyclopropyl]-1-oxopropan-2-yl (2z)-3-(3,4-dihydroxyphenyl)prop-2-enoate
methyl 4-(3-formyl-4,6-dihydroxy-2,5-dimethylbenzoyloxy)-2-hydroxy-3,5,6-trimethylbenzoate
(1r,2s)-1-(3-hydroxy-4,5-dimethoxyphenyl)-2-methyl-3-oxobutyl 2h-1,3-benzodioxole-5-carboxylate
6-({[2-(c-hydroxycarbonimidoyl)phenyl]amino}methyl)-9-methoxyphenazine-1-carboxylic acid
methyl (11s)-15,17-dihydroxy-7-methoxy-5,16-dimethyl-13-oxo-2,10,12-trioxatetracyclo[9.6.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3(8),4,6,14(18),15-hexaene-4-carboxylate
(2r,3r)-2-(2,5-dihydroxyphenyl)-3,5,7-trihydroxy-6-methoxy-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
4,4,16,17-tetramethyl-9-phenyl-6,12,18-trioxapentacyclo[12.4.0.0²,⁷.0³,⁵.0⁸,¹³]octadeca-1,7,9,13-tetraene-11,15-dione
(7s,8s,8as)-8-hydroxy-3-(3-hydroxyprop-1-en-1-yl)-7-methyl-6-oxo-8,8a-dihydro-1h-isochromen-7-yl 2,4-dihydroxy-6-methylbenzoate
methyl (1s,4as,7s,7as)-7-formyl-7-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7ah-cyclopenta[c]pyran-4-carboxylate
C17H22O11 (402.11620619999997)
3-[2,4-dihydroxy-3-(3-hydroxy-3-methylbutyl)-5-methoxyphenyl]-5,7-dihydroxychromen-4-one
methyl 7-(furan-3-yl)-9-methyl-4,14-dioxo-3,6,13-trioxapentacyclo[10.2.2.1²,⁵.0¹,¹⁰.0⁵,⁹]heptadecane-15-carboxylate
(1s,10r,13s,15r)-1-hydroxy-10-methyl-13-(4-oxoquinazolin-3-yl)-8,11-diazatetracyclo[6.6.1.0²,⁷.0¹¹,¹⁵]pentadeca-2,4,6-triene-9,12-dione
(2r,3s)-2-hydroxy-2-[(4-hydroxyphenyl)methyl]-3-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}butanedioic acid
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(4-hydroxyphenoxy)oxan-2-yl]methyl (2e)-3-phenylprop-2-enoate
3-[2,3-dihydroxy-4-methoxy-5-(2-methylbut-3-en-2-yl)phenyl]-3,5,7-trihydroxy-2h-1-benzopyran-4-one
11-{2,2,8,8-tetramethylpyrano[2,3-h]chromen-6-yl}-4,6,10-trioxatricyclo[7.3.0.0³,⁷]dodeca-1,3(7),8,11-tetraene
3-[(3-chloro-4-hydroxyphenyl)methyl]-4-hydroxy-4-isopropyl-5-[(4-methoxyphenyl)methylidene]oxolan-2-one
C22H23ClO5 (402.12339380000003)
4-methoxy-6-{[(1s,2r,5r)-1,2,5-trihydroxy-3-oxo-2-(2-oxo-2-phenylethyl)cyclohexyl]methyl}pyran-2-one
(3r,5as,6s,10ar)-3-benzyl-1,6-dihydroxy-3,10a-bis(methylsulfanyl)-5ah,6h,10h-pyrazino[1,2-a]indol-4-one
C20H22N2O3S2 (402.10717819999996)
(1s,4as,7s,7as)-4-(methoxycarbonyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7h,7ah-cyclopenta[c]pyran-7-carboxylic acid
C17H22O11 (402.11620619999997)
(1r,2r,4s,5r,6s,9s,10r,11s,13s)-10-chloro-2,11-dihydroxy-2,6,11-trimethyl-7-oxo-8,14-dioxatetracyclo[8.4.0.0¹,¹³.0⁵,⁹]tetradecan-4-yl 2-methylpropanoate
(1r,2e,8s,10s)-6-[(acetyloxy)methyl]-1,10-dimethyl-5,13-dioxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6,11-trien-8-yl 2-methylprop-2-enoate
4-(methoxycarbonyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7h,7ah-cyclopenta[c]pyran-7-carboxylic acid
C17H22O11 (402.11620619999997)
12,15-dimethoxy-5,5-dimethyl-14-phenyl-6,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,8,11(16),12,14-heptaen-8-ol
(2r,3s)-2-benzyl-3-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-2-hydroxybutanedioic acid
methyl 7-formyl-7-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7ah-cyclopenta[c]pyran-4-carboxylate
C17H22O11 (402.11620619999997)
2,3-dihydroxypropyl 1,6-dihydroxy-8-methoxy-3-methyl-9,10-dioxoanthracene-2-carboxylate
2-[(7-hydroxy-4-methoxyphenanthren-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3s)-2-hydroxy-2-[(4-hydroxyphenyl)methyl]-3-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}butanedioic acid
(3e,5r)-5-(4-hydroxy-3,5-dimethoxyphenyl)-3-[(4-hydroxy-3,5-dimethoxyphenyl)methylidene]oxolan-2-one
6,7,8-trimethoxy-3-(3,4,5-trimethoxyphenyl)chromen-4-one
(3e,3as,4s,8bs)-8,8-dimethyl-3-({[(2r)-4-methyl-5-oxo-2h-furan-2-yl]oxy}methylidene)-2,7-dioxo-3ah,4h,5h,6h,8bh-indeno[1,2-b]furan-4-yl acetate
(3e)-8,8-dimethyl-3-{[(4-methyl-5-oxo-2h-furan-2-yl)oxy]methylidene}-2,7-dioxo-3ah,4h,5h,6h,8bh-indeno[1,2-b]furan-4-yl acetate
(2s,4's,9s,9ar)-2-methyl-4'-(4-oxoquinazolin-3-yl)-2,9a-dihydro-1h-spiro[imidazo[1,2-a]indole-9,2'-oxolane]-3,5'-dione
9-(acetyloxy)-8,8-dimethyl-2-oxo-9h,10h-pyrano[2,3-h]chromen-10-yl 2,3-dimethyloxirane-2-carboxylate
5-hydroxy-6-[1-(1-hydroxy-6-methyl-5,8-dioxonaphthalen-2-yl)ethyl]-2-methylnaphthalene-1,4-dione
(6r,7r)-7-hydroxy-3-[(1e)-3-hydroxyprop-1-en-1-yl]-7-methyl-8-oxo-5,6-dihydro-1h-isochromen-6-yl 2,4-dihydroxy-6-methylbenzoate
5-hydroxy-9-(4-hydroxyphenyl)-2,2-dimethyl-6-(3-methylbuta-1,3-dien-1-yl)pyrano[2,3-h]chromen-10-one
1-[(1s,2s)-2-[(s)-hydroxy[(2r)-6-oxo-2,3-dihydropyran-2-yl]methyl]cyclopropyl]-1-oxopropan-2-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
(2r,3s,4e)-5-[(2s,3r,3ar,7ar)-3-hydroxy-5-oxo-2h,3h,3ah,7ah-furo[3,2-b]pyran-2-yl]-3-[(e)-benzoyloxy]pent-4-en-2-yl acetate
methyl (1s,2s,5s,7r,9s,10s,12r,15r)-7-(furan-3-yl)-9-methyl-4,14-dioxo-3,6,13-trioxapentacyclo[10.2.2.1²,⁵.0¹,¹⁰.0⁵,⁹]heptadecane-15-carboxylate
(1s,3r,4r,5r,6s)-3,5,6-trihydroxy-1-methoxy-3,6-bis(4-methoxyphenyl)-7-oxabicyclo[2.2.1]heptan-2-one
(2r,3r,4s,6r,11'r,15'r)-3,4,4'-trihydroxy-6-methyl-12',16'-dioxaspiro[oxane-2,17'-tetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadecane]-1'(10'),3',5',7'-tetraene-2',9',13'-trione
2-(2h-1,3-benzodioxol-5-yl)-7-hydroxy-3,5,6,8-tetramethoxychromen-4-one
3-benzyl-1,6-dihydroxy-3,10a-bis(methylsulfanyl)-5ah,6h,10h-pyrazino[1,2-a]indol-4-one
C20H22N2O3S2 (402.10717819999996)
(2s,3s,4s,6s,11's,15's)-3,4,4'-trihydroxy-6-methyl-12',16'-dioxaspiro[oxane-2,17'-tetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadecane]-1'(10'),3',5',7'-tetraene-2',9',13'-trione
(9r,10r)-10-(acetyloxy)-8,8-dimethyl-2-oxo-9h,10h-pyrano[2,3-h]chromen-9-yl 2,3-dimethyloxirane-2-carboxylate
(7s,13r)-9-hydroxy-7-(4-hydroxyphenyl)-13-phenyl-4,14-dioxatricyclo[8.4.0.0³,⁸]tetradeca-1,3(8),9-triene-5,11-dione
(3r,4r,5z)-3-[(3-chloro-4-hydroxyphenyl)methyl]-4-hydroxy-4-isopropyl-5-[(4-methoxyphenyl)methylidene]oxolan-2-one
C22H23ClO5 (402.12339380000003)
3,5,6-trihydroxy-1-methoxy-3,6-bis(4-methoxyphenyl)-7-oxabicyclo[2.2.1]heptan-2-one
(10r,11r)-6,6,10,11-tetramethyl-4-phenyl-10,11-dihydro-1,5,9-trioxatriphenylene-2,12-dione
3-[2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]prop-2-enoic acid
2-hydroxy-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}anthracene-9,10-dione
(9r,10r)-10-(acetyloxy)-8,8-dimethyl-2-oxo-9h,10h-pyrano[2,3-h]chromen-9-yl (2r,3r)-2,3-dimethyloxirane-2-carboxylate
4-(2,4-dihydroxy-6-methylbenzoyloxy)-2-(2-hydroxypropan-2-yl)-6-methyl-2,3-dihydro-1-benzofuran-7-carboxylic acid
(2e)-3-[(2s,3r)-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]prop-2-enoic acid
(7r,13s)-9-hydroxy-13-(4-hydroxyphenyl)-7-phenyl-4,14-dioxatricyclo[8.4.0.0³,⁸]tetradeca-1,3(8),9-triene-5,11-dione
3-[8-hydroxy-2-(hydroxymethyl)-3-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1,4-benzodioxin-6-yl]prop-2-enal
methyl (2s,5s,7r,9s,10s,15s)-7-(furan-3-yl)-9-methyl-4,14-dioxo-3,6,13-trioxapentacyclo[10.2.2.1²,⁵.0¹,¹⁰.0⁵,⁹]heptadecane-15-carboxylate
11-hydroxy-5-methyl-2-{2-methyl-3-[(1z)-prop-1-en-1-yl]oxiran-2-yl}-1-oxatetraphene-4,7,12-trione
9-hydroxy-7-(4-hydroxyphenyl)-13-phenyl-4,14-dioxatricyclo[8.4.0.0³,⁸]tetradeca-1,3(8),9-triene-5,11-dione
8-hydroxy-3-(3-hydroxyprop-1-en-1-yl)-7-methyl-6-oxo-8,8a-dihydro-1h-isochromen-7-yl 2,4-dihydroxy-6-methylbenzoate
11-hydroxy-7,7-dimethyl-15-(2-methylprop-1-en-1-yl)-2,8,16-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-1(14),3,5,9,11,17,19,21-octaen-13-one
5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one
2-chloro-7-[(1e)-hex-1-en-1-yl]-1,6,8-trihydroxy-3-methoxyanthracene-9,10-dione
C21H19ClO6 (402.08701040000005)
5,6-dimethoxy-2-(2,3,5,6-tetramethoxyphenyl)chromen-4-one
(10r,11s)-6,6,10,11-tetramethyl-4-phenyl-10,11-dihydro-1,5,9-trioxatriphenylene-2,12-dione
(3ar,8ar)-6-bromo-1-methyl-3a,8-bis(3-methylbut-2-en-1-yl)-3h,8ah-pyrrolo[2,3-b]indol-2-one
(3r)-3-[2,3-dihydroxy-4-methoxy-5-(2-methylbut-3-en-2-yl)phenyl]-3,5,7-trihydroxy-2h-1-benzopyran-4-one
(1s,4as,7as)-7-(methoxycarbonyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid
C17H22O11 (402.11620619999997)
(3ar,4r,5r,9ar,9bs)-4-(acetyloxy)-9a-hydroxy-6,9-dimethyl-3-methylidene-2,7-dioxo-3ah,4h,5h,9bh-azuleno[4,5-b]furan-5-yl 2-methylprop-2-enoate
5,6,7-trimethoxy-2-(2,4,5-trimethoxyphenyl)chromen-4-one
(2e)-1-(2-hydroxyphenyl)-3-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-en-1-one
(2s)-1-[(5s,6r)-5-hydroxy-6-methyl-2-oxo-5,6-dihydropyran-3-yl]propan-2-yl 3,3,3-trifluoro-2-methoxy-2-phenylpropanoate
(1s,2r,4ar,5r,8r,8as)-8-(acetyloxy)-5-bromo-2-isopropyl-4a,8-dimethyl-octahydronaphthalen-1-yl acetate
5-(4-hydroxy-3,5-dimethoxyphenyl)-3-[(4-hydroxy-3,5-dimethoxyphenyl)methylidene]oxolan-2-one
(2r)-1-[(1s,2s)-2-[(s)-hydroxy[(2r)-6-oxo-2,3-dihydropyran-2-yl]methyl]cyclopropyl]-1-oxopropan-2-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
(6r,7r)-6-hydroxy-3-[(1e)-3-hydroxyprop-1-en-1-yl]-7-methyl-8-oxo-5,6-dihydro-1h-isochromen-7-yl 2,4-dihydroxy-6-methylbenzoate
methyl (1s,4ar,7r,7as)-7-formyl-7-hydroxy-1-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7ah-cyclopenta[c]pyran-4-carboxylate
C17H22O11 (402.11620619999997)
(17s)-13-hydroxy-4-(hydroxymethyl)-5,17-dimethoxy-7,12-dimethyl-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(11),3,5,7,12,14(18)-hexaene-9,15-dione
(2e)-3-[(2s,3s)-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-8-methoxy-2,3-dihydro-1,4-benzodioxin-6-yl]prop-2-enal
7-hydroxy-5,6,8-trimethoxy-2-(7-methoxy-2h-1,3-benzodioxol-5-yl)chromen-4-one
2-{6-hydroxy-2-[(4-hydroxyphenyl)methyl]-1-benzofuran-7-yl}-6-(hydroxymethyl)oxane-3,4,5-triol
3-(benzoyloxy)-5-{3-hydroxy-5-oxo-2h,3h,3ah,7ah-furo[3,2-b]pyran-2-yl}pent-4-en-2-yl acetate
5,7-dihydroxy-2-(4-hydroxyphenyl)-6-(3,4,5-trihydroxyoxan-2-yl)chromen-4-one
5,6,11-trihydroxy-9-methoxy-22-oxahexacyclo[10.10.2.0²,⁷.0⁸,²⁴.0¹⁵,²³.0¹⁶,²¹]tetracosa-2(7),3,5,8(24),9,11,16,18,20-nonaen-13-one
(3ar,4r,9r,9ar)-4,6,7-trihydroxy-9-(3,4,5-trimethoxyphenyl)-3h,3ah,4h,9h,9ah-naphtho[2,3-c]furan-1-one
4-(acetyloxy)-9a-hydroxy-6,9-dimethyl-3-methylidene-2,7-dioxo-3ah,4h,5h,9bh-azuleno[4,5-b]furan-5-yl 2-methylprop-2-enoate
7-hydroxy-3-(3-hydroxyprop-1-en-1-yl)-7-methyl-8-oxo-5,6-dihydro-1h-isochromen-6-yl 2,4-dihydroxy-6-methylbenzoate
10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfanyl)-5λ⁶-phenothiazine-5,5-dione
1-{3-[(2s,3s,4ar,6r,7s,8s,8ar)-7,8-dihydroxy-2,6-bis(hydroxymethyl)-hexahydro-2h-pyrano[2,3-b][1,4]dioxin-3-yl]-2,4,6-trihydroxyphenyl}ethanone
C17H22O11 (402.11620619999997)
3,4,4'-trihydroxy-6-methyl-12',16'-dioxaspiro[oxane-2,17'-tetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadecane]-1'(10'),3',5',7'-tetraene-2',9',13'-trione
(3e,5s)-5-(4-hydroxy-3,5-dimethoxyphenyl)-3-[(4-hydroxy-3,5-dimethoxyphenyl)methylidene]oxolan-2-one
4-hydroxy-2-(5-hydroxy-3,7,8-trimethoxy-4-oxochromen-2-yl)phenyl acetate
5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one
3-[3-(4-hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-8-methoxy-2,3-dihydro-1,4-benzodioxin-6-yl]prop-2-enal
(2r,3r)-2-(3,4-dihydroxy-5-methoxyphenyl)-3,5,7-trihydroxy-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
(15r)-11-hydroxy-7,7-dimethyl-15-(2-methylprop-1-en-1-yl)-2,8,16-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-1(14),3,5,9,11,17,19,21-octaen-13-one
(2s,3r,4s,5s,6r)-2-[(7-hydroxy-4-methoxyphenanthren-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
6,7,10,10-tetramethyl-4-phenyl-6,7-dihydro-1,5,9-trioxatriphenylene-2,8-dione
(1r,15s,23s)-5,6,11-trihydroxy-9-methoxy-22-oxahexacyclo[10.10.2.0²,⁷.0⁸,²⁴.0¹⁵,²³.0¹⁶,²¹]tetracosa-2(7),3,5,8(24),9,11,16,18,20-nonaen-13-one
5-[(1s,3as,4r,6ar)-4-(2h-1,3-benzodioxol-5-yloxy)-3a-hydroxy-tetrahydro-1h-furo[3,4-c]furan-1-yl]-2h-1,3-benzodioxol-4-ol
(2e)-3-[(2s,3s)-8-hydroxy-2-(hydroxymethyl)-3-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1,4-benzodioxin-6-yl]prop-2-enal
(10s,11s)-6,6,10,11-tetramethyl-4-phenyl-10,11-dihydro-1,5,9-trioxatriphenylene-2,12-dione
5-hydroxy-3-[1-(8-hydroxy-3-methyl-1,4-dioxonaphthalen-2-yl)ethyl]-2-methylnaphthalene-1,4-dione
methyl (1r,2r,5r,7r,9s,10s,12s,15s)-7-(furan-3-yl)-9-methyl-4,14-dioxo-3,6,13-trioxapentacyclo[10.2.2.1²,⁵.0¹,¹⁰.0⁵,⁹]heptadecane-15-carboxylate
6-hydroxy-3-(3-hydroxyprop-1-en-1-yl)-7-methyl-8-oxo-5,6-dihydro-1h-isochromen-7-yl 2,4-dihydroxy-6-methylbenzoate
2-chloro-7-(hex-1-en-1-yl)-1,6,8-trihydroxy-3-methoxyanthracene-9,10-dione
C21H19ClO6 (402.08701040000005)
2-hydroxy-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}anthracene-9,10-dione
(1s,4as,7as)-7-(methoxycarbonyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid
C17H22O11 (402.11620619999997)
6-bromo-1-methyl-3a,8-bis(3-methylbut-2-en-1-yl)-3h,8ah-pyrrolo[2,3-b]indol-2-one
4-(methoxycarbonyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7h,7ah-cyclopenta[c]pyran-7-carboxylic acid
C17H22O11 (402.11620619999997)
(9r,10r)-10-(acetyloxy)-8,8-dimethyl-2-oxo-9h,10h-pyrano[2,3-h]chromen-9-yl (2s,3s)-2,3-dimethyloxirane-2-carboxylate
(2r)-2,3-dihydroxypropyl 1,6-dihydroxy-8-methoxy-3-methyl-9,10-dioxoanthracene-2-carboxylate
2-(2,5-dihydroxyphenyl)-3,5,7-trihydroxy-6-methoxy-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
3,5,6,7,8-pentamethoxy-2-(2-methoxyphenyl)chromen-4-one
2-methyl-4'-(4-oxoquinazolin-3-yl)-2,9a-dihydro-1h-spiro[imidazo[1,2-a]indole-9,2'-oxolane]-3,5'-dione
11-hydroxy-5-methyl-2-[2-methyl-3-(prop-1-en-1-yl)oxiran-2-yl]-1-oxatetraphene-4,7,12-trione
(2s,3s)-2-(3,4-dihydroxy-5-methoxyphenyl)-3-(hydroxymethyl)-5-methoxy-2h,3h-[1,4]dioxino[2,3-h]chromen-9-one
6-[(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(4-hydroxyphenoxy)oxan-2-yl]methyl 3-phenylprop-2-enoate
5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one
3-(2,2-dimethylchromen-6-yl)-5-hydroxy-8,8-dimethylpyrano[3,2-g]chromen-4-one
1-{2-[hydroxy(6-oxo-2,3-dihydropyran-2-yl)methyl]cyclopropyl}-1-oxopropan-2-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate
(1r,4s,5s,6s)-5-[(benzoyloxy)methyl]-4-chloro-5,6-dihydroxycyclohex-2-en-1-yl benzoate
C21H19ClO6 (402.08701040000005)
(2r,3r,4s,5s,6r)-2-[(7-hydroxy-4-methoxyphenanthren-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
8-(acetyloxy)-5-bromo-2-isopropyl-4a,8-dimethyl-octahydronaphthalen-1-yl acetate
methyl (1r,2s,5s,7r,9s,10s,12s,15s)-7-(furan-3-yl)-9-methyl-4,14-dioxo-3,6,13-trioxapentacyclo[10.2.2.1²,⁵.0¹,¹⁰.0⁵,⁹]heptadecane-15-carboxylate
5-hydroxy-6-[(1s)-1-(8-hydroxy-3-methyl-1,4-dioxonaphthalen-2-yl)ethyl]-2-methylnaphthalene-1,4-dione
3-[(3,4-dihydroxy-5-methoxyphenyl)methyl]-4-[(7-methoxy-2h-1,3-benzodioxol-5-yl)methyl]oxolan-2-one
5-[(1r,3as,4r,6as)-4-(7-methoxy-2h-1,3-benzodioxol-5-yl)-hexahydrofuro[3,4-c]furan-1-yl]-3-methoxybenzene-1,2-diol
(2s)-3-(acetyloxy)-1-{4-methoxy-7-oxofuro[3,2-g]chromen-6-yl}-3-methylbutan-2-yl acetate
10-(acetyloxy)-8,8-dimethyl-2-oxo-9h,10h-pyrano[2,3-h]chromen-9-yl 2,3-dimethyloxirane-2-carboxylate
(1s,2e,8s,10s)-6-[(acetyloxy)methyl]-1,10-dimethyl-5,13-dioxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6,11-trien-8-yl 2-methylprop-2-enoate
(7s,8s,8as)-7-hydroxy-3-[(1e)-3-hydroxyprop-1-en-1-yl]-7-methyl-6-oxo-8,8a-dihydro-1h-isochromen-8-yl 2,4-dihydroxy-6-methylbenzoate
2-(3,4-dihydroxy-5-methoxyphenyl)-3,5,7-trihydroxy-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
(1r,4as,7r,7as)-4-(methoxycarbonyl)-1-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,7h,7ah-cyclopenta[c]pyran-7-carboxylic acid
C17H22O11 (402.11620619999997)
7-(methoxycarbonyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid
C17H22O11 (402.11620619999997)
